PL1776587T3 - Zastosowanie C3A i jego pochodnych jako biomarkera do leczenia gruczolaka i/lub raka jelita grubego; metody diagnostyczne i testy z ich użyciem - Google Patents

Zastosowanie C3A i jego pochodnych jako biomarkera do leczenia gruczolaka i/lub raka jelita grubego; metody diagnostyczne i testy z ich użyciem

Info

Publication number
PL1776587T3
PL1776587T3 PL05772471T PL05772471T PL1776587T3 PL 1776587 T3 PL1776587 T3 PL 1776587T3 PL 05772471 T PL05772471 T PL 05772471T PL 05772471 T PL05772471 T PL 05772471T PL 1776587 T3 PL1776587 T3 PL 1776587T3
Authority
PL
Poland
Prior art keywords
colorectal
carcinoma
colorectal adenoma
biomarker
adenoma
Prior art date
Application number
PL05772471T
Other languages
English (en)
Inventor
Hartmut Juhl
Kerstin David
Anne-Kristin Fentz
Original Assignee
Indivumed Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34958684&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1776587(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Indivumed Gmbh filed Critical Indivumed Gmbh
Publication of PL1776587T3 publication Critical patent/PL1776587T3/pl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57419—Specifically defined cancers of colon
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/78—Thyroid gland hormones, e.g. T3, T4, TBH, TBG or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/76—Assays involving albumins other than in routine use for blocking surfaces or for anchoring haptens during immunisation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
PL05772471T 2004-08-13 2005-08-11 Zastosowanie C3A i jego pochodnych jako biomarkera do leczenia gruczolaka i/lub raka jelita grubego; metody diagnostyczne i testy z ich użyciem PL1776587T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/EP2004/009124 WO2006015616A1 (en) 2004-08-13 2004-08-13 Use of transthyretin as a biomarker for colorectal adenoma and/or carcinoma; method for detection and test system
EP05772471A EP1776587B9 (en) 2004-08-13 2005-08-11 Use of c3a and derivatives thereof as biomarker for colorectal adenoma and/or carcinoma ; diagnosis methods and assays using the same
PCT/EP2005/008742 WO2006053592A1 (en) 2004-08-13 2005-08-11 Use of c3a and derivatives thereof as a biomarker for colorectal ademona and/or carcinoma; diagnosis method and test system using the same

Publications (1)

Publication Number Publication Date
PL1776587T3 true PL1776587T3 (pl) 2009-06-30

Family

ID=34958684

Family Applications (2)

Application Number Title Priority Date Filing Date
PL04764118T PL1761779T3 (pl) 2004-08-13 2004-08-13 Zastosowanie transtyretyny jako biomarkera gruczolaka jelita grubego; sposób wykrywania i układ testowy
PL05772471T PL1776587T3 (pl) 2004-08-13 2005-08-11 Zastosowanie C3A i jego pochodnych jako biomarkera do leczenia gruczolaka i/lub raka jelita grubego; metody diagnostyczne i testy z ich użyciem

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL04764118T PL1761779T3 (pl) 2004-08-13 2004-08-13 Zastosowanie transtyretyny jako biomarkera gruczolaka jelita grubego; sposób wykrywania i układ testowy

Country Status (20)

Country Link
US (2) US7951528B2 (pl)
EP (3) EP1761779B1 (pl)
JP (2) JP4916441B2 (pl)
KR (1) KR20070051328A (pl)
CN (2) CN101014859A (pl)
AT (2) ATE376674T1 (pl)
AU (2) AU2004322162B2 (pl)
BR (1) BRPI0419002A (pl)
CA (2) CA2577601A1 (pl)
DE (2) DE602004009716T2 (pl)
DK (2) DK1761779T3 (pl)
ES (2) ES2295907T3 (pl)
IL (2) IL181132A (pl)
MX (2) MX2007001479A (pl)
NO (2) NO20070598L (pl)
PL (2) PL1761779T3 (pl)
PT (2) PT1761779E (pl)
SI (1) SI1776587T1 (pl)
WO (2) WO2006015616A1 (pl)
ZA (1) ZA200701188B (pl)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE376674T1 (de) 2004-08-13 2007-11-15 Indivumed Gmbh Verwendung von transthyretin als biomarker zum nachweis von kolorektalen adenomen; verfahren und nachweis-system
EP1775590A1 (en) * 2005-10-11 2007-04-18 Laboratorios S.A.L.V.A.T., S.A. Non-invasive in vitro method to detect transitional cell carcinoma of the bladder
JP4748671B2 (ja) * 2006-03-16 2011-08-17 日東紡績株式会社 食道扁平上皮癌マーカーおよびそれを利用した食道扁平上皮癌の判定方法
KR100819122B1 (ko) 2006-09-30 2008-04-04 남명진 췌장암 진단용 키트
JP5570810B2 (ja) * 2007-08-18 2014-08-13 学校法人北里研究所 大腸癌マーカポリペプチド、及び大腸癌の診断方法
JP5203687B2 (ja) * 2007-12-12 2013-06-05 シスメックス株式会社 動物検査情報提供システム、中央装置、動物検査情報提供方法及びコンピュータプログラム
CN101838683B (zh) * 2008-12-12 2013-09-18 深圳华大基因科技有限公司 一种kras基因和/或braf基因的核苷酸突变位点的检测方法
CN102147396B (zh) * 2010-02-10 2014-01-01 桑建利 人血液样本中脂类分子含量测定及其结直肠腺瘤诊断试剂盒制备与应用
JP2013253780A (ja) * 2010-10-12 2013-12-19 Katakura Industries Co Ltd うつ病の診断のためのデータの提供方法
US10158898B2 (en) 2012-07-26 2018-12-18 Comcast Cable Communications, Llc Customized options for consumption of content
WO2014085826A2 (en) * 2012-11-30 2014-06-05 Applied Proteomics, Inc. Method for evaluation of presence of or risk of colon tumors
CN104056277B (zh) * 2013-03-21 2019-07-05 中国人民解放军第二军医大学 Mlh1基因或其表达产物在dkk4高表达的结直肠癌中的应用
AU2015237229A1 (en) * 2014-03-28 2016-11-10 Applied Proteomics, Inc. Protein biomarker profiles for detecting colorectal tumors
JP6750140B2 (ja) * 2014-08-22 2020-09-02 アボット・ラボラトリーズＡｂｂｏｔｔ Ｌａｂｏｒａｔｏｒｉｅｓ 直腸結腸がんを早期検出するための方法
CN105988006A (zh) * 2015-02-10 2016-10-05 张曼 尿液补体c3蛋白的应用
EP3281016A1 (en) 2015-04-10 2018-02-14 Applied Proteomics Inc. Protein biomarker panels for detecting colorectal cancer and advanced adenoma
US20180092874A1 (en) * 2016-10-03 2018-04-05 Lincoln Memorial University Identification and use of very long chain dicarboxylic acids for disease diagnosis, chemoprevention, and treatment
KR102018205B1 (ko) * 2017-07-24 2019-09-05 (주) 바이오인프라생명과학 대장암 진단용 조성물 및 상기 조성물을 이용한 대장암 진단 방법
GB201721569D0 (en) * 2017-12-21 2018-02-07 Belgian Volition Sprl Method for the detection and treatment of colorectal adenomas
GB201808476D0 (en) * 2018-05-23 2018-07-11 Univ Liverpool Biomarkers for colorectal cancer
WO2023282916A1 (en) 2021-07-09 2023-01-12 Guardant Health, Inc. Methods of detecting genomic rearrangements using cell free nucleic acids
CN116449018B (zh) * 2023-02-14 2023-09-05 浙江大学 一种用于肠腺瘤腺癌诊断的血浆蛋白标记物及应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4996298A (en) * 1988-04-20 1991-02-26 New England Deaconess Hospital Corporation Marker for colorectal carcinoma and methods of detecting the same
US5654161A (en) 1995-05-12 1997-08-05 Chiron Diagnostics Corporation Method for diagnosing prostate cancer
DE19711111C2 (de) 1997-03-06 1999-09-02 Schering Ag In vitro Nachweis zur Erkennung von Darmtumoren
US6221621B1 (en) 1997-03-06 2001-04-24 Bard Diagnostic Sciences, Inc. Methods of screening for colorectal cancers in which a complement Factor I or related protein is associated
IL121134A0 (en) * 1997-06-22 1997-11-20 Yeda Res & Dev Peptides and antiallergic compositions comprising them
WO2002059621A2 (en) 2001-01-24 2002-08-01 Bayer Corporation Regulation of transthyretin to treat obesity
WO2003000182A2 (en) 2001-06-22 2003-01-03 Merck & Co., Inc. Ppar-alpha ligands for the treatment or prevention of cachexia
US7144708B2 (en) * 2001-06-25 2006-12-05 The Cleveland Clinic Foundation Markers of blood barrier disruption and methods of using same
DE10224534A1 (de) 2002-05-31 2003-12-11 Juergen Dolderer Verfahren zum Diagnostizieren des colorektaien Karzinoms in einer Gewebeprobe und Mittel zur Behandlung
JP2005529625A (ja) 2002-06-19 2005-10-06 オンコセラピー・サイエンス株式会社 結腸直腸腫瘍の診断のための方法
US7605003B2 (en) * 2002-08-06 2009-10-20 The Johns Hopkins University Use of biomarkers for detecting ovarian cancer
CA2526878A1 (en) * 2003-04-08 2004-10-21 Colotech A/S A method for detection of colorectal cancer in human samples
WO2005008251A2 (en) * 2003-07-11 2005-01-27 Praecis Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of endometriosis
ATE376674T1 (de) 2004-08-13 2007-11-15 Indivumed Gmbh Verwendung von transthyretin als biomarker zum nachweis von kolorektalen adenomen; verfahren und nachweis-system
WO2006015615A1 (en) 2004-08-13 2006-02-16 Egomedical Technologies Ag Analyte test system for determining the concentration of an analyte in a physiological or aqueous fluid
WO2006102526A2 (en) 2005-03-22 2006-09-28 Government Of The Usa, As Represented By The Secretary, Dept. Of Health And Human Services Identification of biomarkers by serum protein profiling

Also Published As

Publication number Publication date
ES2322378T3 (es) 2009-06-19
DK1776587T3 (da) 2009-04-20
DE602004009716T2 (de) 2008-08-28
WO2006053592A1 (en) 2006-05-26
PL1761779T3 (pl) 2008-04-30
IL181131A0 (en) 2007-07-04
US7951528B2 (en) 2011-05-31
ES2295907T3 (es) 2008-04-16
SI1776587T1 (sl) 2009-06-30
US7883842B2 (en) 2011-02-08
AU2004322162B2 (en) 2011-04-28
DE602005012108D1 (de) 2009-02-12
IL181132A (en) 2011-04-28
IL181131A (en) 2011-03-31
CA2577601A1 (en) 2006-02-16
AU2004322162A2 (en) 2006-02-16
JP2008509409A (ja) 2008-03-27
BRPI0419002A (pt) 2007-12-11
PT1761779E (pt) 2008-02-01
EP1761779B1 (en) 2007-10-24
AU2005306103A1 (en) 2006-05-26
MX2007001479A (es) 2007-07-25
EP1776587A1 (en) 2007-04-25
WO2006015616A1 (en) 2006-02-16
EP1761779A1 (en) 2007-03-14
DK1761779T3 (da) 2008-02-25
KR20070051328A (ko) 2007-05-17
EP1776587B1 (en) 2008-12-31
DE602004009716D1 (de) 2007-12-06
ATE376674T1 (de) 2007-11-15
EP1776587B9 (en) 2009-09-16
NO20070599L (no) 2007-05-14
JP2008509407A (ja) 2008-03-27
NO20070598L (no) 2007-05-14
CN101014859A (zh) 2007-08-08
ZA200701188B (en) 2009-01-28
CN101014861A (zh) 2007-08-08
EP1843159A1 (en) 2007-10-10
ATE419534T1 (de) 2009-01-15
CA2576998A1 (en) 2006-05-26
IL181132A0 (en) 2007-07-04
MX2007001254A (es) 2007-10-05
US20070184499A1 (en) 2007-08-09
US20080160515A1 (en) 2008-07-03
AU2004322162A1 (en) 2006-02-16
JP4592753B2 (ja) 2010-12-08
JP4916441B2 (ja) 2012-04-11
PT1776587E (pt) 2009-04-03

Similar Documents

Publication Publication Date Title
PT1776587E (pt) Utilização de c3a e seus derivados como biomarcador para o adenoma e/ou carcinoma colorrectal; processos de diagnóstico e ensaios utilizando os mesmos
WO2008134526A3 (en) Glycoprotein profiling of bladder cancer
WO2005041893A3 (en) Detection of acute myocardial infarction biomarkers
NO20083820L (no) Deteksjon av kreft ved forhoyede nivaer av BCL-2
WO2010033371A3 (en) Molecular markers for lung and colorectal carcinomas
KR100711046B1 (ko) 대장암에 대한 마커로서의 니코틴아미드ｎ―메틸트랜스퍼라아제의 용도
WO2008109075A3 (en) Biomarkers and methods for determining sensitivity to ctla-4 antagonists
CA2701341A1 (en) Method of assessing colorectal cancer from a stool sample by use of the marker combination calprotectin and hemoglobin/haptoglobin complex
WO2007061940A3 (en) Method for detecting an inflammatory disease or cancer
PL1977244T3 (pl) Rozróżnianie bakteryjnego i wirusowego zapalenia opon mózgowych
ATE467831T1 (de) Verfahren und vorrichtung zum nachweis flüchtiger analyten in luftproben
WO2003102015A3 (en) Method and apparatus for detecting and monitoring peptides, and peptides identified therewith
NO20053276L (no) Fremgangsmate og hjelpemiddel for pavisning av mykoplasma.
IL189185A0 (en) Use of an endoplasmin fragment and derivatives thereof as a biomarker for colorectal adenoma and/or carcinoma; method for detection and test system
WO2007061656A3 (en) Method for detecting ovarian cancer
WO2009063249A3 (en) Early detection of sepsis
DK1416278T3 (da) Fremgangsmåder til forbedret diagnosticering af dysplasier
WO2002000342A3 (en) Method and apparatus for performing an assay
EP1767646A4 (en) PROBE FOR DETECTING / DETERMINING INOSITOL-1,4,5-TRIPHOSPHORIC ACID AND PROCESS FOR DETERMINING / DETERMINING INOSITOL-1,4,5-TRIPHOSPHORIC ACID THEREWITH
BRPI0514314A (pt) método para detecção de e discriminação entre adenoma colorretal e/ou carcinoma colorretal, método para monitoramento de desenvolvimento e/ou curso e/ou de tratamento de adenoma colorretal e/ou carcinoma colorretal, uso de c3a ou derivado do mesmo, sistema de teste, conjunto compreendendo moléculas, método para determinar se um composto é efetivo no tratamento do adenoma colorretal e/ou carcinoma colorretal